The effect of vedolizumab (anti-47-integrin) therapy on colonic mucosal gene expression in patients with ulcerative colitis (UC)

GSE73661

Homo sapiens

175 Downloadable Samples

Affymetrix Human Gene 1.0 ST Array (hugene10st)

Submitter Supplied Information

Description

Microarrays were used to investigate the the effect of vedolizumab (VDZ) therapy on colonic mucosal gene expression in UC patients and compared the changes to those observed with infliximab (IFX) therapy.

PubMed ID

27802155

Publication Title

Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC.

Total Samples

178

Submitter’s Institution

KULeuven

Authors

Arijs I, De Hertogh G, Lemmens B, Van Lommel L, de Bruyn M, Vanhove W, Cleynen I, Machiels K, Ferrante M, Schuit F, Van Assche G, Rutgeerts P, Vermeire S

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-73661

No rows found